Ryaltris (GSP 301)

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company founded in 1977 and headquartered in Mumbai, India. The company operates across the pharmaceutical value chain with significant investments in R&D, particularly in respiratory diseases, dermatology, and oncology. Glenmark has successfully developed and commercialized innovative drugs while building a strong generic pharmaceuticals portfolio across key markets including the US, Europe, and emerging markets.

Therapeutic Areas